Merit Medical Systems Inc (MMSI)
105.03
+0.95
(+0.91%)
USD |
NASDAQ |
Nov 21, 16:00
105.03
0.00 (0.00%)
After-Hours: 20:00
Merit Medical Systems Revenue (Quarterly): 339.84M for Sept. 30, 2024
Revenue (Quarterly) Chart
Historical Revenue (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 339.84M |
| June 30, 2024 | 338.00M |
| March 31, 2024 | 323.51M |
| December 31, 2023 | 324.52M |
| September 30, 2023 | 315.23M |
| June 30, 2023 | 320.06M |
| March 31, 2023 | 297.56M |
| December 31, 2022 | 293.42M |
| September 30, 2022 | 287.18M |
| June 30, 2022 | 294.98M |
| March 31, 2022 | 275.42M |
| December 31, 2021 | 278.49M |
| September 30, 2021 | 267.02M |
| June 30, 2021 | 280.32M |
| March 31, 2021 | 248.91M |
| December 31, 2020 | 258.00M |
| September 30, 2020 | 243.98M |
| June 30, 2020 | 218.37M |
| March 31, 2020 | 243.52M |
| December 31, 2019 | 257.92M |
| September 30, 2019 | 243.05M |
| June 30, 2019 | 255.53M |
| March 31, 2019 | 238.35M |
| December 31, 2018 | 233.25M |
| September 30, 2018 | 221.66M |
| Date | Value |
|---|---|
| June 30, 2018 | 224.81M |
| March 31, 2018 | 203.04M |
| December 31, 2017 | 190.90M |
| September 30, 2017 | 179.34M |
| June 30, 2017 | 186.55M |
| March 31, 2017 | 171.07M |
| December 31, 2016 | 157.72M |
| September 30, 2016 | 156.98M |
| June 30, 2016 | 151.07M |
| March 31, 2016 | 138.08M |
| December 31, 2015 | 138.40M |
| September 30, 2015 | 136.09M |
| June 30, 2015 | 138.08M |
| March 31, 2015 | 129.58M |
| December 31, 2014 | 132.78M |
| September 30, 2014 | 128.81M |
| June 30, 2014 | 128.86M |
| March 31, 2014 | 119.24M |
| December 31, 2013 | 120.02M |
| September 30, 2013 | 115.21M |
| June 30, 2013 | 109.88M |
| March 31, 2013 | 103.95M |
| December 31, 2012 | 102.23M |
| September 30, 2012 | 95.91M |
| June 30, 2012 | 100.53M |
Revenues Definition
Revenues measure the total amount of value that a company brings in during a certain period. This is also considered the "top-line" of the income statement. Revenues are used for all operating expenses as well as other line items which eventually lead to the net income for the company. Revenue is an extremely important metric when analyzing a company. A company with efficient margins is able to turn revenues into the most net income.
Revenue (Quarterly) Range, Past 5 Years
218.37M
Minimum
Jun 2020
339.84M
Maximum
Sep 2024
285.31M
Average
283.75M
Median
Revenue (Quarterly) Benchmarks
| Becton Dickinson & Co | 5.437B |
| Boston Scientific Corp | 4.209B |
| Abbott Laboratories | 10.64B |
| Baxter International Inc | 2.699B |
| ResMed Inc | 1.225B |
Revenue (Quarterly) Related Metrics
| Net Income (Quarterly) | 28.44M |
| Total Expenses (Quarterly) | 302.48M |
| EPS Diluted (Quarterly) | 0.48 |
| Enterprise Value | 6.293B |
| Gross Profit Margin (Quarterly) | 46.36% |
| Profit Margin (Quarterly) | 8.37% |
| Earnings Yield | 1.95% |
| Operating Earnings Yield | 2.47% |
| Normalized Earnings Yield | 1.949 |